Boosting with AstraZeneca’s vaccine and mRNA COVID-19 vaccines provide equally high protection against Omicron-related severe outcomes, including hospitalisation and death, even as new subvariants of the virus emerge, according to an expert review of more than 50 real-world studies. The Read More …
With more than 72 million doses delivered to Vietnam, AstraZeneca’s COVID-19 vaccine is one of the most used in the country and is estimated to have prevented 232,766 deaths locally, an independent assessment of vaccine effectiveness shows.1,2 AstraZeneca’s vaccine was Read More …
Builds on initial US government agreement, now totalling 1.7 million doses Only antibody therapy authorized in the US for pre-exposure prophylaxis of COVID-19 in people who are immunocompromised AstraZeneca today announced the US Department of Health and Human Services has Read More …
University of Oxford study supports use of Vaxzevria as third dose booster against Omicron Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant AstraZeneca’s Read More …
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19 In this pre-clinical study, Evusheld’s Inhibitory Concentration 50 (IC50), a measure of neutralising potency of an antibody, was 171 ng/ml and 277 ng/ml in two confirmatory tests, which is within the Read More …
AstraZeneca and Vietnam Vaccine JSC (VNVC) have delivered an additional 1,547,100 doses of COVID-19 Vaccine AstraZeneca (also known as Vaxzevria) to Vietnam, reaching the milestone of 30 million doses and completing the first phase of the companies’ vaccine supply partnership, Read More …
Only antibody therapy authorised in US for pre-exposure prophylaxis Pivotal phase III data showed robust efficacy and long-term protection with one dose in high-risk population AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency Read More …
Vietnam Prime Minister and AstraZeneca CEO had bilateral telephone conversation today AstraZeneca delivered another 1,209,400 doses of its COVID-19 vaccine to Vietnam. The delivery is the ninth to Vietnam in total as part of the advance purchase agreement (APA) between Read More …
AstraZeneca delivered 592,100 additional doses of its COVID-19 vaccine for use in Vietnam on August 6th, 2021. The delivery is the seventh to Vietnam in total as part of the advance purchase agreement between AstraZeneca and Vietnam Vaccine JSC (VNVC), Read More …
Trial to enroll approximately 2,250 adults to assess safety and immunogenicity of AZD2816 against the SARS-CoV-2 virus The first participants in a Phase II/III trial for the new COVID-19 variant vaccine AZD2816 were vaccinated today to assess its safety and immunogenicity in both Read More …
